Presentation3_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx

Presentation3_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx

<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. However, clinical efficacy data for this vaccine are currently lacking. We previously established the Quantification...

Full description

Saved in:
Bibliographic Details
Main Author: Goh Ohji (5205629) (author)
Other Authors: Yohei Funakoshi (7400786) (author), Kimikazu Yakushijin (4282231) (author), Takaji Matsutani (381798) (author), Tomoki Sasaki (410920) (author), Takahiro Kusakabe (27671) (author), Sakuya Matsumoto (19809291) (author), Taiji Koyama (19809294) (author), Yoshiaki Nagatani (18404734) (author), Keiji Kurata (15128476) (author), Shiro Kimbara (19809297) (author), Naomi Kiyota (562845) (author), Hironobu Minami (411771) (author)
Published: 2024
Subjects:
Immunology
Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
Autoimmunity
Cellular Immunology
Humoural Immunology and Immunochemistry
Immunogenetics (incl. Genetic Immunology)
Innate Immunity
Transplantation Immunology
Tumour Immunology
Immunology not elsewhere classified
Genetic Immunology
Animal Immunology
Veterinary Immunology
mRNA RBD vaccine
B-cell receptor repertoire
coronavirus antibody database
quantification of antigen-specific antibody sequence
SARS-CoV-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items